NCT05188365 is a NA clinical trial of true acupuncture in Tinnitus, Subjective, sponsored by Cairo University.

Who is sponsoring NCT05188365?

NCT05188365 is sponsored by Cairo University.

What drugs are being tested in NCT05188365?

Interventions in NCT05188365: true acupuncture, sham acupuncture.

What condition does NCT05188365 study?

NCT05188365 studies Tinnitus, Subjective, Obesity, Lipids.

Is NCT05188365 still recruiting?

NCT05188365 is currently status unknown. Last updated 28 January 2022.

Last reviewed 2022-01-28 · How we verify

NCT05188365

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Acupuncture Efficacy on Lipids in Tinnitus Patients With Obesity

Status unknown NA Last updated 28 January 2022

What this trial tests

NA trial testing true acupuncture in Tinnitus, Subjective in 60 participants. Status unknown.

Timeline

6 December 2021

Primary endpoint
30 April 2022

30 April 2022

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	60
Start date	6 December 2021
Primary completion	30 April 2022
Estimated completion	30 April 2022
Sites	1 location across Egypt

Drugs / interventions tested

true acupuncture
sham acupuncture

Conditions studied

Tinnitus, Subjective — all drugs for Tinnitus, Subjective →
Obesity — all drugs for Obesity →
Lipids — all drugs for Lipids →

Sponsor

Cairo University

Who can join

Adults 35 to 45, any sex, with Tinnitus, Subjective or Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

nowadays, published literature affirms strong relation between tinnitus, obesity, and high lipids of blood.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Tinnitus, Subjective

Currently open trials in the same condition.

NCT07393880 — Bimodal Electrical-Sound Stimulation and Auditory Training for Chronic Tonal Tinnitus · NA · recruiting
NCT07071480 — Noninvasive Therapy for Tinnitus · NA · recruiting
NCT07017998 — External Therapy for Tinnitus Management · NA · recruiting
NCT06880367 — Neuromodulatory Effects of Audio-proprio-phonatory Reinforcement Training on Subjective Tinnitus, Demonstrated by High-d · NA · recruiting
NCT06782308 — Tinnitus Patient Preferences Survey · recruiting

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05188365 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 28 January 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05188365.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing